Hela SMAD/TGFbeta Reporter (Luc) stable cell line

Hela SMAD/TGFbeta Reporter (Luc) cells are derived from the human cervix adenocarcinoma Hela cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. The Hela cell line has been widely used in cancer research and drug development. Hela SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.